Different Treatment Modalities for Myofascial Pain

Myofascial Pain Clinical Trial

Official title:

Effectiveness of Different Treatment Methods in Patients With Myofascial Pain Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04257903
• Other study ID #: TUFT-BAEK 2019/114
• Status: Completed
• Start date: April 1, 2019
• Est. completion date: April 1, 2019

Study information

• Verified date: February 2020
• Source: Trakya University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Myofascial pain dysfunction syndrome (MPDS) is the most common reason for pain and limited function of the masticatory system. The low-level laser therapy (LLLT) and occlusal splint therapy (OST) are therapeutic options for MPDS. This study aims to evaluate the effect of LLLT and OST on pain relief and mandibular movement improvement in patients with myofascial pain.

Description:

Myofascial pain dysfunction syndrome in the masticatory muscles is the most common temporomandibular disorder. Patients suffer from pain and muscle tenderness and may present with or without restricted mouth opening. The etiology of myofascial pain dysfunction syndrome is multifactorial including psychological factors, occlusion imbalance, and parafunctional habits. Treatments for myofascial pain dysfunction syndrome include education, self-care, physical therapy, use of intra-oral appliances, short-term pharmacotherapy, behavioral therapy, and relaxation techniques.

Temporomandibular disorder is most often treated using occlusal splints safely to reduce temporomandibular joint load, and subsequently, clinical symptoms, as a reversible therapy. Occlusal splints need to be used for at least three months to eliminate temporomandibular disorders.

One of physical therapy is laser treatment. Laser treatment on tissues provides a clinical effect called biostimulation, where the basic mechanism occurs at the molecular level.

The low-level laser has non-invasive and inoffensive characteristics at appropriate parameters.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: April 1, 2019
• Est. primary completion date: April 1, 2019
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Diagnosis of myofascial pain syndrome according to The Research Diagnostic Criteria for Temporomandibular Disorder.

• Individuals between the ages of 18-60

• Occlusion of individuals with posterior teeth

• Forms of individuals who do not have any systemic disease

Exclusion Criteria:

• Disc displacement with or without reduction, with or without limited mouth opening, arthralgia, arthritis, arthrosis

• Inflammatory connective tissue disease (such as rheumatoid arthritis)

• Psychiatric diseases

• Tumor

• Heart diseases

• Pregnancy

• Diseases that may cause pain symptoms in other orofacial regions (toothache, neuralgia, migraine)

• Having received any treatment for headache or bruxism in the last 2 years

• Skin infections on the masseter and temporal muscles

Related Conditions & MeSH terms

• Low-Level Laser Therapy
• Myofascial Pain
• Myofascial Pain Syndromes
• Splints

Locations

Country	Name	City	State
Turkey	Trakya University	Merkez	Edirne

Sponsors (1)

Lead Sponsor	Collaborator
Trakya University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from Baseline Visual Analogue Scale	Pain intensity during muscle palpations. Scores are ranging from 0 to 10. Higher scores mean a worse outcome.	Baseline, one month after the beginning of treatment and two months after the beginning of treatment
Secondary	Change from Baseline maximum unassisted mouth opening	Value of Maximum unassisted mouth opening as a centimeter. Scores are ranging from 0 to 45 centimeters. Higher scores mean a better outcome.	Baseline, one month after the beginning of treatment and two months after the beginning of treatment